Literature DB >> 26295814

Neuroprotective Effects of the Securinine-Analogues: Identification of Allomargaritarine as a Lead Compound.

Margarita E Neganova, Sergei G Klochkov, Svetlana V Afanasieva, Tatiana P Serkova, Ekaterina S Chudinova, Sergei O Bachurin, V Prakash Reddy, Gjumrakch Aliev1, Elena F Shevtsova.   

Abstract

Oxidative stress and mitochondrial disturbances are the common and important causative factors of aging, and play an important role in the late onset of sporadic neurodegenerative diseases, including Alzheimer disease (AD). Furthermore, emerging evidence from in vitro and in vivo disease models suggests that oxidative stress and increased vulnerability to induction of mitochondrial permeability transition leads to the pathogenesis of the neurological disorders. Towards the goals of developing effective neuroprotectors, this article describes the synthesis and neuroprotective studies of various derivatives of the naturally occurring alkaloid securinine, based on which a lead compound, allomargaritarine (a diastereomer of margaritarine), was identified as an effective therapeutic for neuroprotection. Allomargaritarine exhibits high antioxidant activity, and has significant mitoprotective effect on cellular models of neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26295814     DOI: 10.2174/1871527314666150821111812

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  3 in total

1.  L-securinine inhibits the proliferation of A549 lung cancer cells and promotes DKK1 promoter methylation.

Authors:  Shuwen Han; Xi Yang; Yuefen Pan; Quan Qi; Junjun Shen; Huifen Fang; Zhaoning Ji
Journal:  Oncol Lett       Date:  2017-08-01       Impact factor: 2.967

Review 2.  Unique indolizidine alkaloid securinine is a promising scaffold for the development of neuroprotective and antitumor drugs.

Authors:  Sergey Klochkov; Margarita Neganova
Journal:  RSC Adv       Date:  2021-05-26       Impact factor: 4.036

3.  Promising Molecular Targets for Pharmacological Therapy of Neurodegenerative Pathologies.

Authors:  M E Neganova; Yu R Aleksandrova; V O Nebogatikov; S G Klochkov; A A Ustyugov
Journal:  Acta Naturae       Date:  2020 Jul-Sep       Impact factor: 1.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.